| |
| |
|
| Insider
Information: |
Sachdev Amit |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
71,325 |
|
|
Indirect Shares
|
7,447 |
|
|
| Direct
Value |
$26,276,609 |
|
|
|
Indirect Value
|
$3,536,953 |
|
|
| Total
Shares |
78,772 |
|
|
| Total
Value |
$29,813,561 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2014-11-17 |
4 |
AS |
$111.97 |
$15,004 |
D/D |
(134) |
78,671 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2014-11-28 |
4 |
AS |
$120.00 |
$1,440,000 |
D/D |
(12,000) |
78,671 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2015-01-09 |
4 |
AS |
$125.00 |
$1,500,000 |
D/D |
(12,000) |
78,671 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2015-02-18 |
4 |
AS |
$112.62 |
$670,256 |
D/D |
(5,937) |
89,984 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2015-03-18 |
4 |
AS |
$130.00 |
$1,560,000 |
D/D |
(12,000) |
89,984 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2015-03-20 |
4 |
AS |
$135.08 |
$1,620,960 |
D/D |
(12,000) |
89,984 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2015-03-23 |
4 |
AS |
$122.78 |
$638,756 |
D/D |
(5,083) |
84,901 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2015-05-15 |
4 |
AS |
$123.85 |
$16,224 |
D/D |
(131) |
84,901 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2015-10-30 |
4 |
AS |
$123.34 |
$745,433 |
D/D |
(5,938) |
78,963 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2015-11-16 |
4 |
AS |
$122.28 |
$10,394 |
D/D |
(85) |
78,963 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2016-02-03 |
4 |
AS |
$89.91 |
$923,460 |
D/D |
(10,166) |
86,096 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2016-05-16 |
4 |
AS |
$81.67 |
$9,555 |
D/D |
(117) |
86,096 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2016-11-15 |
4 |
AS |
$93.36 |
$10,830 |
D/D |
(116) |
86,096 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-02-13 |
4 |
AS |
$87.68 |
$673,733 |
D/D |
(7,684) |
99,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-03-29 |
4 |
AS |
$106.30 |
$8,664,568 |
D/D |
(80,500) |
99,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-05-15 |
4 |
AS |
$114.37 |
$13,267 |
D/D |
(116) |
99,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-06-01 |
4 |
AS |
$125.00 |
$3,812,500 |
D/D |
(30,500) |
99,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-07-19 |
4 |
AS |
$161.00 |
$3,220,000 |
D/D |
(20,000) |
99,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-07-21 |
4 |
AS |
$158.05 |
$1,386,691 |
D/D |
(8,625) |
90,710 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-10-31 |
4 |
AS |
$142.40 |
$5,802,084 |
D/D |
(40,000) |
50,710 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-11-15 |
4 |
AS |
$147.29 |
$12,225 |
D/D |
(83) |
50,710 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-19 |
4 |
AS |
$157.67 |
$5,125,400 |
D/D |
(32,422) |
39,163 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-22 |
4 |
AS |
$160.00 |
$2,200,000 |
D/D |
(13,750) |
39,163 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-23 |
4 |
AS |
$165.00 |
$960,960 |
D/D |
(5,824) |
39,163 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-29 |
4 |
AS |
$170.00 |
$2,564,450 |
D/D |
(15,085) |
39,163 |
0 |
- |
|
193 Records found
|
|
Page 3 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
